Success Stories: A Postdoctoral Associate in the field of Biomedical Science from Bangladesh Earns EB2-NIW Approval

Client’s Testimonial:

“I am incredibly grateful for the vigorous support and expertise of my immigration attorney throughout the successful approval of my I-140 petition. Their responses were consistently prompt, and their case writing was exceptional—thorough, well-organized, and enriched with relevant scientific citations that added strong weight to my petition.

I was particularly impressed by how carefully they analyzed and enhanced my research profile, crafting compelling statements around my journal articles and clearly articulating their scientific and societal impact. Their orientation toward scientific writing and attention to detail in presenting my work were instrumental to the strength of the petition.

I am fully satisfied with their service and would highly recommend them to any researcher seeking expert guidance in the immigration process.”

On April 1^st, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Associate in the Field of Biomedical Science (Approval Notice).

General Field: Biomedical Science

Position at the Time of Case Filing: Postdoctoral Associate

Country of Origin: Bangladesh

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: April 1^st, 2025

Processing Time: 10 months and 9 days

Case Summary:

A Postdoctoral Associate from Bangladesh specializing in biomedical science has secured swift approval for his I-140 petition under the EB-2 National Interest Waiver (NIW) category with our law firm. His research centers on the development of targeted nanocarriers for RNA delivery and mRNA purification, work that addresses critical challenges in cancer therapy and vaccine manufacturing. His petition was approved by USCIS without a Request for Evidence (RFE), recognizing the value and urgency of his contributions to U.S. public health and biomedical innovation.

A strong profile grounded in impactful research.

When reviewing the client’s profile, our legal team quickly recognized the national relevance of his work. We devised a tailored petition strategy that highlighted his innovative therapeutic approaches, growing academic recognition, and impactful publication record in cancer nanotechnology and RNA medicine.

Track record of scientific contributions and global recognition

To support the petition, we presented a strong collection of documentation outlining the client’s academic and research success, including:

● 12 peer-reviewed journal articles, including 5 first-authored papers and 1 preprint

● 172 citations to his work, reflecting broad engagement by independent researchers globally

● At least 4 papers ranked among the top 10–20% most cited in Pharmacology & Toxicology for their year of publication

● Published in highly ranked journals such as Pharmaceutics, Biomedicines, Nanomaterials, and Archives of Pharmacal Research

● Research supported by the Malaysian Fundamental Research Grant Scheme, which funds projects that promote innovation, enhance quality of life, and contribute to strategic national agendas.

Proposed endeavor to benefit U.S. public health innovation

With a Ph.D. in biomedical science, the client plans to continue his research in the United States about synthesizing tumor-targeted nanocarriers for RNA therapeutic delivery and improving mRNA purification systems. His proposed work aims to develop cost-effective and scalable solutions for cancer vaccines and RNA-based therapies, directly supporting national priorities in precision medicine and pandemic preparedness.

NIW approval granted in 10 months and 9 days

We are pleased to report that his NIW petition was approved in just 10 months and 9 days, without a Request for Evidence. We congratulate our client on this well-earned success and are proud to support his continued impact on advancing life-saving technologies at the intersection of nanomedicine and public health.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.